Vikrant Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vikrant Singh has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Heike Wulff
Department of Pharmacology School of Medicine University of California Davis California USA
4 shared publications - Pamela J. Lein
University of California, Davis
4 shared publications - Shiv Govind Singh
Department of Electrical Engineering, Indian Institute of Technology Hyderabad, Telangana, India
3 shared publications - Suryasnata Tripathy
Department of Electrical Engineering, Indian Institute of Technology, Hyderabad, India
3 shared publications - Danielle Jenine Harvey
Department of Public Health Sciences, University of California, Davis, Davis, CA, USA
2 shared publications - Siva Rama Krishna Vanjari
Department of Electrical Engineering, Indian Institute of Technology, Hyderabad, India
2 shared publications
Latest Publications
- Open Access
- 15 April 2025
- Published by Springer Nature in Discover Water
- Vol. 5 (1) , 1-17
Multivariate analysis of water quality of Sacramento-San Joaquin Delta
- 15 April 2025
- Published by Springer Nature in Discover Water
- Vol. 5 (1) , 1-17
Open AccessMultivariate analysis of water quality of Sacramento-San Joaquin Delta
- 18 March 2021
- Published by Elsevier in NeuroToxicology
- Vol. 84, 96-104
Investigation of NH3 as a selective thyroid hormone receptor modulator in larval zebrafish (Danio rerio)
- 18 March 2021
- Published by Elsevier in NeuroToxicology
- Vol. 84, 96-104
Investigation of NH3 as a selective thyroid hormone receptor modulator in larval zebrafish (Danio rerio)
- 3 August 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (8) , 4195-4212
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
Characterization of the key cellular targets contributing to sustained microglial activation in neurodegenerative diseases, including Parkinson’s disease (PD), and optimal modulation of these targets can provide potential treatments to halt disease progression. Here, we demonstrated that microglial Kv1.3, a voltage-gated potassium channel, was transcriptionally upregulated in response to aggregated α-synuclein (αSynAgg) stimulation in primary microglial cultures and animal models of PD, as well as in postmortem human PD brains. Patch-clamp electrophysiological studies confirmed that the observed Kv1.3 upregulation translated to increased Kv1.3 channel activity. The kinase Fyn, a risk factor for PD, modulated transcriptional upregulation and posttranslational modification of microglial Kv1.3. Multiple state-of-the-art analyses, including Duolink proximity ligation assay imaging, revealed that Fyn directly bound to Kv1.3 and posttranslationally modified its channel activity. Furthermore, we demonstrated the functional relevance of Kv1.3 in augmenting the neuroinflammatory response by using Kv1.3-KO primary microglia and the Kv1.3-specific small-molecule inhibitor PAP-1, thus highlighting the importance of Kv1.3 in neuroinflammation. Administration of PAP-1 significantly inhibited neurodegeneration and neuroinflammation in multiple animal models of PD. Collectively, our results imply that Fyn-dependent regulation of Kv1.3 channels plays an obligatory role in accentuating the neuroinflammatory response in PD and identify Kv1.3 as a potential therapeutic target for PD.
- 3 August 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (8) , 4195-4212
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
Characterization of the key cellular targets contributing to sustained microglial activation in neurodegenerative diseases, including Parkinson’s disease (PD), and optimal modulation of these targets can provide potential treatments to halt disease progression. Here, we demonstrated that microglial Kv1.3, a voltage-gated potassium channel, was transcriptionally upregulated in response to aggregated α-synuclein (αSynAgg) stimulation in primary microglial cultures and animal models of PD, as well as in postmortem human PD brains. Patch-clamp electrophysiological studies confirmed that the observed Kv1.3 upregulation translated to increased Kv1.3 channel activity. The kinase Fyn, a risk factor for PD, modulated transcriptional upregulation and posttranslational modification of microglial Kv1.3. Multiple state-of-the-art analyses, including Duolink proximity ligation assay imaging, revealed that Fyn directly bound to Kv1.3 and posttranslationally modified its channel activity. Furthermore, we demonstrated the functional relevance of Kv1.3 in augmenting the neuroinflammatory response by using Kv1.3-KO primary microglia and the Kv1.3-specific small-molecule inhibitor PAP-1, thus highlighting the importance of Kv1.3 in neuroinflammation. Administration of PAP-1 significantly inhibited neurodegeneration and neuroinflammation in multiple animal models of PD. Collectively, our results imply that Fyn-dependent regulation of Kv1.3 channels plays an obligatory role in accentuating the neuroinflammatory response in PD and identify Kv1.3 as a potential therapeutic target for PD.
- 1 January 2020
- Published by Elsevier in NeuroToxicology
- Vol. 76, 220-234
Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists
- 1 January 2020
- Published by Elsevier in NeuroToxicology
- Vol. 76, 220-234
Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists
- Open Access
Conditional KCa3.1-Transgene Induction in Murine Skin Produces Pruritic Eczematous Dermatitis With Severe Epidermal Hyperplasia and Hyperkeratosis
Ion channels have recently attracted attention as potential mediators of skin disease. Here, we explored the consequences of genetically encoded induction of the cell volume-regulating Ca 2+ -activated KCa3.1 channel ( Kcnn4 ) for murine epidermal homeostasis. Doxycycline-treated mice harboring the KCa3.1+-transgene under the control of the reverse tetracycline-sensitive transactivator (rtTA) showed 800-fold channel overexpression above basal levels in the skin and solid KCa3.1-currents in keratinocytes. This overexpression resulted in epidermal spongiosis, progressive epidermal hyperplasia and hyperkeratosis, itch and ulcers. The condition was accompanied by production of the pro-proliferative and pro-inflammatory cytokines, IL-β1 (60-fold), IL-23 (34-fold), IL-6 (33-fold), and TNFα (26-fold) in the skin. Treatment of mice with the KCa3.1-selective blocker, Senicapoc, significantly suppressed spongiosis and hyperplasia, as well as induction of IL-β1 (−88%), IL-23 (−77%), and IL-6 (−90%). In conclusion, KCa3.1-induction in the epidermis caused expression of pro-proliferative cytokines leading to spongiosis, hyperplasia and hyperkeratosis. This skin condition resembles pathological features of eczematous dermatitis and identifies KCa3.1 as a regulator of epidermal homeostasis and spongiosis, and as a potential therapeutic target.
Open AccessConditional KCa3.1-Transgene Induction in Murine Skin Produces Pruritic Eczematous Dermatitis With Severe Epidermal Hyperplasia and Hyperkeratosis
Ion channels have recently attracted attention as potential mediators of skin disease. Here, we explored the consequences of genetically encoded induction of the cell volume-regulating Ca 2+ -activated KCa3.1 channel ( Kcnn4 ) for murine epidermal homeostasis. Doxycycline-treated mice harboring the KCa3.1+-transgene under the control of the reverse tetracycline-sensitive transactivator (rtTA) showed 800-fold channel overexpression above basal levels in the skin and solid KCa3.1-currents in keratinocytes. This overexpression resulted in epidermal spongiosis, progressive epidermal hyperplasia and hyperkeratosis, itch and ulcers. The condition was accompanied by production of the pro-proliferative and pro-inflammatory cytokines, IL-β1 (60-fold), IL-23 (34-fold), IL-6 (33-fold), and TNFα (26-fold) in the skin. Treatment of mice with the KCa3.1-selective blocker, Senicapoc, significantly suppressed spongiosis and hyperplasia, as well as induction of IL-β1 (−88%), IL-23 (−77%), and IL-6 (−90%). In conclusion, KCa3.1-induction in the epidermis caused expression of pro-proliferative cytokines leading to spongiosis, hyperplasia and hyperkeratosis. This skin condition resembles pathological features of eczematous dermatitis and identifies KCa3.1 as a regulator of epidermal homeostasis and spongiosis, and as a potential therapeutic target.
- 1 September 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 141, 111441
Electrospun tin (IV) oxide nanofiber based electrochemical sensor for ultra-sensitive and selective detection of atrazine in water at trace levels
- 1 September 2019
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 141, 111441
Electrospun tin (IV) oxide nanofiber based electrochemical sensor for ultra-sensitive and selective detection of atrazine in water at trace levels
- 1 April 2017
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 90, 378-387
Electrospun manganese (III) oxide nanofiber based electrochemical DNA-nanobiosensor for zeptomolar detection of dengue consensus primer
- 1 April 2017
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 90, 378-387
Electrospun manganese (III) oxide nanofiber based electrochemical DNA-nanobiosensor for zeptomolar detection of dengue consensus primer
- 18 February 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (5) , 1870-1876
Chasing the Elusive Benzofuran Impurity of the THR Antagonist NH-3: Synthesis, Isotope Labeling, and Biological Activity
We have synthesized and established the structure of a long-suspected, but hitherto unknown, benzofuran side product (EBI) formed during the synthesis of NH-3. Understanding the mechanism of its formation has enabled isotope (D) labeling. We further developed a highly efficient method for separating EBI from NH-3. Interestingly, EBI was found to be a very potent thyroid hormone receptor (THR) agonist, while NH-3 is an antagonist. In this process, we have also achieved a significantly improved synthesis of NH-3.
- 18 February 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (5) , 1870-1876
Chasing the Elusive Benzofuran Impurity of the THR Antagonist NH-3: Synthesis, Isotope Labeling, and Biological Activity
We have synthesized and established the structure of a long-suspected, but hitherto unknown, benzofuran side product (EBI) formed during the synthesis of NH-3. Understanding the mechanism of its formation has enabled isotope (D) labeling. We further developed a highly efficient method for separating EBI from NH-3. Interestingly, EBI was found to be a very potent thyroid hormone receptor (THR) agonist, while NH-3 is an antagonist. In this process, we have also achieved a significantly improved synthesis of NH-3.